MAL2 and triple-negative breast carcinoma: To further explore if Z8 can also influence the pathway of MAL2/MUC1-C/PI3K/AKT/mTOR, we treatment MDA-MB-231 and MDA-MB-468 triple-negative breast cancer cell lines with Z839878730.